Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

West Pharmaceutical Services, Inc. WST

Healthcare  —  Medical Instruments & Supplies
370.44 (3.16) (0.85%) as of 25 Sep
Market cap
$26.3B
P/E
47.1×
S&P 500 Member Dividend Aristocrat
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

West Pharmaceutical Services, Inc. (WST) EV/EBITDA

As of 25 September 2026, West Pharmaceutical Services, Inc. (WST) trades at a EV/EBITDA of 30.2×. Over the past ten years it has ranged from 13.0× (February 2015) to 47.9× (September 2021); the current reading is higher than 70% of that period. That is above the Medical Instruments & Supplies industry median of 16.1× and above the Healthcare sector median of 10.4×.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2025 25.5× (21.66%)
FY2024 32.6× 5.45%
FY2023 30.9× 57.60%
FY2022 19.6× (50.08%)
FY2021 39.3× (1.52%)
FY2020 39.9× 45.78%
FY2019 27.4× 32.73%
FY2018 20.6× (9.14%)
FY2017 22.7× 4.83%
FY2016 21.6× 10.19%

Quarterly

Period EV/EBITDA Change
Jun 2026 29.2× 37.09%
Mar 2026 21.3× (16.48%)
Dec 2025 25.5× 3.81%
Sep 2025 24.6× 18.08%
42 more quarters

Against its own ten years

Low 13.0× High 47.9×
Ten-year median 25.6×
Current reading's percentile 70

EV/EBITDA against peers

Company EV/EBITDA
MDLN Medline Inc. compare 3.9×
SOLV Solventum Corporation compare 7.9×
ALC Alcon compare 12.7×
BDX Becton, Dickinson and Company compare 13.3×
BAX Baxter International Inc. compare 13.3×
COO The Cooper Companies, Inc. compare 14.1×
RMD ResMed Inc. compare 14.7×
WST West Pharmaceutical Services, Inc. 30.2×
RGEN Repligen Corporation compare 65.3×
Medical Instruments & Supplies industry median 16.1×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on WST